type here...

CATEGORIES

Press Release

LATEST

1...101112Page 11 of 12

TRENDING

EDITORS CHOICE

St. Jude scientists identify possible COVID-19 treatment in the lab

Medika Life -
If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

NICO.LAB Ready to Revolutionize U.S. Stroke Care After FDA Clearance

Medika Life -
An artificial intelligence algorithm for fast triaging of stroke patients. StrokeViewer LVO detects image characteristics associated with a Large Vessel Occlusion (LVO)

Lives Cost from Meager Paid Sick Leave at Walmart

Medika Life -
Walmart’s failure to have a paid sick leave policy that met the needs of associates and their families during the COVID-19 pandemic has cost 138 deaths that could have been avoided.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories